Pars Darou

Pars Darou is a prominent Iranian pharmaceutical company that specializes in the production of generic medicines across various therapeutic areas. Founded in 1960 as a joint venture with Hoechst, the company has evolved into a major player in the regional market, manufacturing over 100 different products including tablets, capsules, and topical formulations. Its portfolio is particularly strong in dermatology, cardiovascular health, and internal medicine. As a publicly traded company on the Tehran Stock Exchange, Pars Darou operates under the umbrella of the Tamin Pharmaceutical Investment Company (TPICO). The firm maintains high-quality manufacturing standards and is a key supplier to the Iranian healthcare system.